ProfileGDS4177 / 220717_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 11% 8% 20% 49% 7% 9% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated8.5211
GSM603099KU-812 non-treated7.538
GSM603098KCL-22 Imatinib-treated10.3920
GSM603097KCL-22 non-treated30.7349
GSM603102JURL-MK1 Imatinib-treated7.257
GSM603101JURL-MK1 non-treated7.769